Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc

c-Myc is a key oncogenic transcription factor that participates in tumor pathogenesis. In this study, we found that levels of c-Myc mRNA and protein were higher in early ovarian cancer tissues than normal ovary samples. Increased c-Myc levels correlated positively with clinical stage I (Ia+b/Ic) in ovarian cancer patients. Patients with higher nuclear c-Myc expression had shorter overall survival times than patients with low c-Myc expression. Knocking down c-Myc sensitized ovarian cancer cells to 7-difluoromethoxyl-5,4’-di-n-octylgenistein (DFOG), a novel synthetic genistein analogue that suppressed PI3K/AKT signaling in vitro and in vivo. Finally, c-Myc was confirmed to be a direct target of let-7d, and let-7d-induced suppression of c-Myc increased the DFOG-sensitivity of ovarian cancer cells. These results indicate that nuclear c-Myc expression is an unfavorable factor in early ovarian cancer, and that let-7d increases ovarian cancer cell sensitivity to DFOG by suppressing c-Myc and PI3K/AKT signaling.

[1]  Q. Fu,et al.  miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin , 2017, Oncogene.

[2]  M. Nam,et al.  Genistein induces apoptosis by down-regulating thioredoxin-1 in human hepatocellular carcinoma SNU-449 cells. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  Feng-jun Liu,et al.  Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway , 2016, Oncotarget.

[4]  S. Chiou,et al.  Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model , 2016, Oncotarget.

[5]  Xiaobo Song,et al.  Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia , 2016, Oncotarget.

[6]  A. Hajitou,et al.  The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction , 2016, Oncotarget.

[7]  Y. Yang,et al.  Genistein-induced apoptosis is mediated by endoplasmic reticulum stress in cervical cancer cells. , 2016, European review for medical and pharmacological sciences.

[8]  John T. Powers,et al.  Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma , 2016, Nature.

[9]  Q. Fu,et al.  miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR–p-PI3K/AKT-c-JUN , 2016, Nature Communications.

[10]  M. Manikandan,et al.  Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism , 2016, Molecular Cancer.

[11]  A. Giordano,et al.  Let‐7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma‐Derived 3AB‐OS Cancer Stem Cells , 2016, Journal of cellular physiology.

[12]  G. Jiang,et al.  Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma , 2016, Oncotarget.

[13]  J. Beaulieu,et al.  Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells , 2015, Oncogene.

[14]  Xiaoming Yang,et al.  SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer , 2015, PloS one.

[15]  A. Gompel,et al.  Hormone therapy and ovarian cancer , 2015, The Lancet.

[16]  B. Karlan,et al.  Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers , 2015, International journal of cancer.

[17]  A. Sood,et al.  Targeting c-MYC in Platinum-Resistant Ovarian Cancer , 2015, Molecular Cancer Therapeutics.

[18]  Q. Cai,et al.  MDM4 regulation by the let‐7 miRNA family in the DNA damage response of glioma cells , 2015, FEBS letters.

[19]  Hansjuerg Alder,et al.  MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression , 2015, Oncotarget.

[20]  Daniela Alfano,et al.  c-Myc modulation: a key role in melanoma drug response , 2015, Cancer biology & therapy.

[21]  Qiu-ying Liu,et al.  Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway , 2015, Molecular Cancer.

[22]  G. Sauter,et al.  Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer , 2015, BMC Gastroenterology.

[23]  Shu Yan,et al.  Piperlongumine reverses doxorubicin resistance through the PI3K/Akt signaling pathway in K562/A02 human leukemia cells , 2015, Experimental and therapeutic medicine.

[24]  Zhiquan Hu,et al.  Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer. , 2015, International journal of clinical and experimental pathology.

[25]  Wei Zhao,et al.  Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7 , 2014, Molecular Cancer.

[26]  Jianguo Cao,et al.  FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein. , 2014, Molecular medicine reports.

[27]  Jianguo Cao,et al.  7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1 , 2014, Oncology letters.

[28]  O. Olopade,et al.  MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency , 2013, Tumor Biology.

[29]  M. Cole,et al.  Molecular and Cellular Pathobiology Myc Acts via the Pten Tumor Suppressor to Elicit Autoregulation and Genome-wide Gene Repression by Activation of the Ezh2 Methyltransferase , 2022 .

[30]  H. Ye,et al.  [Construction of let-7d expression vector and its inhibitory effect on HMGA2 and ras expression in human ovarian cancer cells in vitro]. , 2012, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[31]  S. Volinia,et al.  Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples , 2012, Modern Pathology.

[32]  A. Menssen,et al.  Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer , 2012, Oncotarget.

[33]  Fei Liu,et al.  Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells. , 2012, Oncology reports.

[34]  S. Pyndiah,et al.  c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance , 2011, Science Signaling.

[35]  A. Svindland,et al.  Regulation of PBX3 expression by androgen and Let-7d in prostate cancer , 2011, Molecular Cancer.

[36]  S. Srikantan,et al.  HuR recruits let-7/RISC to repress c-Myc expression. , 2009, Genes & development.

[37]  S. Chow,et al.  Overexpression of cyclin D1 and c-Myc gene products in human primary epithelial ovarian cancer , 2004, International Journal of Gynecologic Cancer.